BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34699080)

  • 1. Adverse drug reactions induced by cotrimoxazole: Still a lot of preventable harm.
    Coppry M; Duret S; Berdaï D; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Rogues AM; Noize P
    Fundam Clin Pharmacol; 2022 Apr; 36(2):421-426. PubMed ID: 34699080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
    Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.
    Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
    Castillon G; Salvo F; Moride Y
    Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre.
    Jonville-Béra AP; Saissi H; Bensouda-Grimaldi L; Beau-Salinas F; Cissoko H; Giraudeau B; Autret-Leca E
    Drug Saf; 2009; 32(5):429-40. PubMed ID: 19419237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.
    Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
    Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
    Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
    Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
    Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
    S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventability of Adverse Drug Reactions Related to Antibiotics: An Assessment Based on Spontaneous Reporting System.
    Tran HN; Nguyen TNT; Tran NTK; Nguyen LT; Vu HD; Nguyen AH; Trinh NTH
    Ther Innov Regul Sci; 2023 Sep; 57(5):1104-1112. PubMed ID: 37389792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
    Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
    Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance system.
    Monteiro C; Duarte AP; Alves G
    Expert Opin Drug Saf; 2021 Jan; 20(1):109-118. PubMed ID: 33170742
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases.
    Patel TK; Bhabhor PH; Desai N; Shah S; Patel PB; Vatsala E; Panigrahi S
    Asian J Psychiatr; 2015 Oct; 17():42-9. PubMed ID: 26216702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients.
    Schmiedl S; Rottenkolber M; Szymanski J; Drewelow B; Siegmund W; Hippius M; Farker K; Guenther IR; Hasford J; Thuermann PA;
    Expert Opin Drug Saf; 2018 Feb; 17(2):125-137. PubMed ID: 29258401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports.
    Egron A; Olivier-Abbal P; Gouraud A; Babai S; Combret S; Montastruc JL; Bondon-Guitton E
    Target Oncol; 2015 Jun; 10(2):229-34. PubMed ID: 25056801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.